A different anticancer therapeutic strategy may involve the targeting of cancer cells using anticancer drugs with metal-binding properties, such as doxorubicin and bleomycin, some of which are capable of forming stable ternary iron complexes with transferrin, similar to iron maltol, which could be transferred and incorporated by transferrin into cancer cells [87,220]. This evidence concerns the gene TF and cancer.